Breaking News

KBI Biopharma, Selexis Open State-of-the-Art Facility in Geneva

The KBI and Selexis co-location will expand biopharmaceutical development and manufacturing capabilities.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

KBI Biopharma SA and Selexis SA, both JSR Life Sciences companies, held a joint ribbon-cutting ceremony at their new state-of-the-art facility in Geneva, Switzerland. Designed to support increased demand for biopharmaceutical drug development and manufacturing in Europe, the facility will provide an integrated, end-to-end process of Selexis’ cell line development (CLD) services along with KBI’s contract development and manufacturing services for industry clients throughout the immediate region a...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters